Jiri Neuzil Selected Research

Antineoplastic Agents (Antineoplastics)

1/2019	Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2.
1/2015	Evaluation of respiration of mitochondria in cancer cells exposed to mitochondria-targeted agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiri Neuzil Research Topics

Disease

111	Neoplasms (Cancer) 05/2024 - 03/2002
15	Malignant Mesothelioma 04/2023 - 05/2004
11	Mesothelioma 01/2015 - 01/2004
9	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2005
9	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2015
8	Carcinogenesis 01/2023 - 06/2009
5	Pheochromocytoma 10/2023 - 01/2020
5	Inflammation (Inflammations) 04/2023 - 10/2002
5	Tics (Tic) 01/2017 - 01/2009
4	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 09/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 12/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 07/2010
3	Hypoxia (Hypoxemia) 05/2024 - 04/2010
3	Melanoma (Melanoma, Malignant) 05/2024 - 08/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 09/2012
3	Disease Progression 12/2021 - 01/2019
3	Paraganglioma (Paragangliomas) 07/2021 - 01/2020
3	Iron Overload 01/2021 - 01/2003
3	Brain Neoplasms (Brain Tumor) 01/2020 - 09/2005
3	Carcinoma (Carcinomatosis) 03/2013 - 02/2010
3	Atherosclerosis 03/2012 - 01/2002
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 06/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2016
2	Parkinson Disease (Parkinson's Disease) 04/2021 - 01/2019
2	Lung Neoplasms (Lung Cancer) 05/2018 - 08/2006
2	Glioma (Gliomas) 01/2016 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 02/2014 - 01/2012
2	Wounds and Injuries (Trauma) 03/2008 - 07/2005
2	Osteosarcoma (Osteogenic Sarcoma) 02/2006 - 06/2005
1	Colonic Neoplasms (Colon Cancer) 05/2024
1	Testicular Neoplasms (Testicular Cancer) 12/2023
1	Myocardial Infarction 10/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023

Drug/Important Bio-Agent (IBA)

35	Succinic Acid (Succinate)IBA 11/2022 - 05/2004
23	Vitamin E FDA LinkGeneric 06/2015 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2005
13	alpha-Tocopherol FDA Link 10/2020 - 05/2002
12	Mitochondrial DNA (mtDNA)IBA 01/2023 - 12/2011
11	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 09/2006
11	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2011
9	Tamoxifen FDA LinkGeneric 05/2024 - 01/2017
8	Adenosine Triphosphate (ATP)IBA 12/2023 - 09/2006
8	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2008
8	EnzymesIBA 11/2022 - 03/2002
7	AsbestosIBA 04/2023 - 01/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2007
4	triphenylphosphoniumIBA 05/2024 - 06/2011
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2023 - 01/2021
4	Phosphotransferases (Kinase)IBA 10/2022 - 02/2011
4	IronIBA 01/2021 - 01/2003
3	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 12/2016
3	Oxygen (Dioxygen)IBA 05/2024 - 03/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2010
3	pyrimidineIBA 01/2022 - 01/2019
3	Chelating AgentsIBA 01/2021 - 01/2003
3	Dihydroorotate DehydrogenaseIBA 01/2020 - 01/2019
3	EsterasesIBA 09/2012 - 02/2007
2	LipidsIBA 01/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
2	AntioxidantsIBA 07/2021 - 02/2007
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 01/2012
2	Pyruvic Acid (Pyruvate)IBA 01/2020 - 11/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2018 - 03/2002
2	CytokinesIBA 03/2018 - 01/2007
2	LigandsIBA 03/2018 - 03/2002
2	ThymidineIBA 01/2016 - 01/2016
2	MesothelinIBA 12/2015 - 04/2011
2	Peroxidase (Myeloperoxidase)IBA 11/2014 - 03/2012
2	Cytochromes c (Cytochrome c)IBA 11/2014 - 03/2012
2	RotenoneIBA 11/2014 - 02/2013
2	TeaIBA 09/2012 - 09/2012
2	Ether (Diethyl Ether)IBA 09/2012 - 09/2012
2	UbiquinoneIBA 10/2011 - 02/2007
2	Peptides (Polypeptides)IBA 04/2011 - 04/2007
2	Death Domain ReceptorsIBA 02/2010 - 01/2007
2	Thioctic Acid (Lipoic Acid)IBA 03/2008 - 07/2005
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2008 - 10/2007
2	TNF-Related Apoptosis-Inducing LigandIBA 05/2006 - 01/2004
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 07/2005 - 06/2004
2	pyridoxal isonicotinoyl hydrazoneIBA 01/2004 - 01/2003
1	Atovaquone (Mepron)FDA Link 05/2024
1	Green Fluorescent ProteinsIBA 05/2024
1	ElementsIBA 05/2024
1	IACS-010759IBA 05/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2024
1	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2023
1	dimemorfan (AT 17)IBA 01/2023
1	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 01/2023
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2023
1	AS 8IBA 01/2023
1	succinyl-coenzyme A (succinyl-CoA)IBA 11/2022
1	Ligases (Synthetase)IBA 11/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2022
1	phenethyl isothiocyanate (PEITC)IBA 10/2022
1	bafilomycin A1IBA 10/2022

Therapy/Procedure

42	Therapeutics 12/2023 - 09/2005
6	Drug Therapy (Chemotherapy) 12/2020 - 11/2006
2	Immunotherapy 05/2024 - 01/2022
2	Radiotherapy 05/2024 - 01/2019